GET THE APP

Biopharmaceuticals Impact Factor | Open Access Journals
Pharmacoeconomics: Open Access

Pharmacoeconomics: Open Access

ISSN: 2472-1042

Open Access

Biopharmaceuticals Impact Factor

Biopharmaceuticals are medical drugs produced using biotechnology. They are proteins including RNA or antisense oligonucleotides, antibodies, nucleic acids DNA used for in vivo diagnostic purposes, and are produced by means other than direct extraction from a native  biological source. The first such substance approved for therapeutic use was recombinant human insulin. Biopharmaceuticals are medical drugs produced using biotechnology. They are proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) used for therapeutic or in vivo diagnostic purposes, and are produced by means other than direct extraction from a native (non-engineered) biological source. The large majority of biopharmaceutical products are pharmaceuticals that are derived from life forms. A potentially controversial method of producing biopharmaceuticals involves transgenic organisms, particularly plants and animals that have been genetically modified to produce drugs.  The large majority of biopharmaceutical products are pharmaceuticals that are derived from life forms. Small molecule drugs are not typically regarded as biopharmaceutical in nature by the industry. However members of the press and the business and financial community often extend the definition to include pharmaceuticals not created through biotechnology. That is, the term has become an oft-used buzzword for a variety of different companies producing new, apparently high-tech pharmaceutical products.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Pharmaceutical Sciences

arrow_upward arrow_upward